Literature DB >> 31472981

Ductal carcinoma in situ of breast: update 2019.

Sunil S Badve1, Yesim Gökmen-Polar2.   

Abstract

Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. It presents several diagnostic and management challenges in part due to its relatively indolent behaviour. Most series analysing biomarkers in these lesions are small (<100 patients) and large clinical trials have not been frequent. Herein, we review the recent progress made in understanding the biology of this entity and the tools available for prognostication.
Copyright © 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; DCIS; ductal carcinoma in situ; molecular features; pathology

Mesh：

Year:  2019        PMID： 31472981      PMCID： PMC6788802          DOI： 10.1016/j.pathol.2019.07.005

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


  74 in total

1.  Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.

Authors:  Robert Lesurf; Miriam Ragle Aure; Hanne Håberg Mørk; Valeria Vitelli; Steinar Lundgren; Anne-Lise Børresen-Dale; Vessela Kristensen; Fredrik Wärnberg; Michael Hallett; Therese Sørlie
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

2.  Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features.

Authors:  Shona Hendry; Jia-Min B Pang; David J Byrne; Sunil R Lakhani; Margaret C Cummings; Ian G Campbell; G Bruce Mann; Kylie L Gorringe; Stephen B Fox
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

3.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Authors:  R Salgado; C Denkert; S Demaria; N Sirtaine; F Klauschen; G Pruneri; S Wienert; G Van den Eynden; F L Baehner; F Penault-Llorca; E A Perez; E A Thompson; W F Symmans; A L Richardson; J Brock; C Criscitiello; H Bailey; M Ignatiadis; G Floris; J Sparano; Z Kos; T Nielsen; D L Rimm; K H Allison; J S Reis-Filho; S Loibl; C Sotiriou; G Viale; S Badve; S Adams; K Willard-Gallo; S Loi
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

4.  Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).

Authors:  Sevilay Altintas; Jerome Toussaint; Virginie Durbecq; Kathleen Lambein; Manon T Huizing; Denis Larsimont; Eric Van Marck; Jan B Vermorken; Wiebrem A Tjalma; Christos Sotiriou
Journal:  Breast J       Date:  2011-06-06       Impact factor: 2.431

5.  Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.

Authors:  Mary F Dillon; Enda W McDermott; Cecily M Quinn; Ann O'Doherty; Niall O'Higgins; Arnold D K Hill
Journal:  J Surg Oncol       Date:  2006-06-01       Impact factor: 3.454

6.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Authors:  Irene L Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Stewart J Anderson; Thomas B Julian; Stephanie R Land; Richard G Margolese; Sandra M Swain; Joseph P Costantino; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2011-03-11       Impact factor: 13.506

7.  Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

Authors:  Lorie L Hughes; Molin Wang; David L Page; Robert Gray; Lawrence J Solin; Nancy E Davidson; Mary Ann Lowen; James N Ingle; Abram Recht; William C Wood
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

Review 8.  Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results.

Authors:  N Sneige; M D McNeese; E N Atkinson; F C Ames; B Kemp; A Sahin; A G Ayala
Journal:  Hum Pathol       Date:  1995-06       Impact factor: 3.466

9.  Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Authors:  Sylvia Adams; Robert J Gray; Sandra Demaria; Lori Goldstein; Edith A Perez; Lawrence N Shulman; Silvana Martino; Molin Wang; Vicky E Jones; Thomas J Saphner; Antonio C Wolff; William C Wood; Nancy E Davidson; George W Sledge; Joseph A Sparano; Sunil S Badve
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

10.  Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.

Authors:  Monica Morrow; Kimberly J Van Zee; Lawrence J Solin; Nehmat Houssami; Mariana Chavez-MacGregor; Jay R Harris; Janet Horton; Shelley Hwang; Peggy L Johnson; M Luke Marinovich; Stuart J Schnitt; Irene Wapnir; Meena S Moran
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544
View more
  10 in total

1.  Value of ultrasound elastography combined with contrast-enhanced ultrasound and micro-flow imaging in differential diagnosis of benign and malignant breast lesions.

Authors:  Zuopeng Ding; Weiyong Liu; Nianan He; Xiaopeng Ma; Lili Fu; Lei Ye
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 2.  Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management.

Authors:  Shelby Lynn Hophan; Olena Odnokoz; Huiping Liu; Yuan Luo; Seema Khan; William Gradishar; Zhuan Zhou; Sunil Badve; Mylin A Torres; Yong Wan
Journal:  Endocrinology       Date:  2022-04-01       Impact factor: 4.736

Review 3.  The accuracy of magnetic resonance imaging in predicting the size of pure ductal carcinoma in situ: a systematic review and meta-analysis.

Authors:  Ricardo Roque; Mariana Robalo Cordeiro; Mónica Armas; Francisco Caramelo; Filipe Caseiro-Alves; Margarida Figueiredo-Dias
Journal:  NPJ Breast Cancer       Date:  2022-06-29

4.  Is conservative management of ductal carcinoma in situ risky?

Authors:  Lan Zheng; Yesim Gökmen-Polar; Sunil S Badve
Journal:  NPJ Breast Cancer       Date:  2022-04-28

5.  Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.

Authors:  Zeyu Xing; Menglu Zhang; Xin Wang; Jiaqi Liu; Gang Liu; Kexin Feng; Xiang Wang
Journal:  J Mol Histol       Date:  2021-05-19       Impact factor: 2.611

6.  Clinicopathological Characteristics of Breast Ductal Carcinoma In Situ: An Analysis of Chinese Population of 617 Patients.

Authors:  Guangmin Mao; Xiu-Hua Shi; Xiaofang Wang; Xiaomeng Zhang; Xingxing Chen; Jinli Ma; Xiaoli Yu; Zhen Zhang; Xiaomao Guo
Journal:  J Oncol       Date:  2021-01-05       Impact factor: 4.375

7.  Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion.

Authors:  Chunyan Li; Yilan Yang; Jiangfeng Wang; Kairui Jin; Zhaozhi Yang; Xiaoli Yu; Xiaomao Guo; Xingxing Chen
Journal:  Cancer Med       Date:  2021-09-21       Impact factor: 4.452

8.  Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy.

Authors:  Hemei Zhou; Jing Yu; Xiaodong Wang; Kunwei Shen; Jiandong Ye; Xiaosong Chen
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

9.  Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.

Authors:  Fengyuan Lv; Mingliang Cheng; Liang Jiang; Xiaoping Zhao
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

10.  Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes.

Authors:  Xiaoping Li; Qihe Yu; Jishang Chen; Hui Huang; Zhuangsheng Liu; Chengxing Wang; Yaoming He; Xin Zhang; Weiwen Li; Chao Li; Jinglin Zhao; Wansheng Long
Journal:  PeerJ       Date:  2020-11-04       Impact factor: 2.984
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.